X2U93YASupplement Right Atrium with Intraluminal Device, Heterotopic Bioprosthetic Valve(s), Percutaneous Approach, New Technology Group 10

  • Billable / Specific Code
ICD-10-PCS X2U93YA
CMS Source: FY 2027 ICD-10-PCS dataset. Effective Oct 1, 2026 – Sep 30, 2027.FacebookXLinkedInPrint

X2U93YA is a billable ICD-10-PCS procedure code for Supplement Right Atrium with Intraluminal Device, Heterotopic Bioprosthetic Valve(s), Percutaneous Approach, New Technology Group 10. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027) and groups to MS-DRGs 266, 267. The root operation Supplement involves putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part. In AHRQ's Clinical Classifications Software (CCSR), this procedure falls under Heart valve replacement and other valve procedures (endovascular).

Code Identity

ICD-10-PCS Code
X2U93YA
Billable Status
Yes — Valid for Submission
Code Describes
Supplement Right Atrium with Intraluminal Device, Heterotopic Bioprosthetic Valve(s), Percutaneous Approach, New Technology Group 10
Short Description
Supplement R Atrium w Hetrtop Bioprst Vlv, Perc, New Tech 10
Parent Code
X2U New Technology, Cardiovascular System, Supplement

PCS Table Breakdown

Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.

PositionDesignationValueMeaning
1SectionXNew Technology
2Body System2Cardiovascular System
3OperationUSupplement
4BodyPart9Atrium, Right
5Approach3Percutaneous
6Device/Substance/TechnologyYIntraluminal Device, Heterotopic Bioprosthetic Valve(s)
7QualifierANew Technology Group 10

In the ICD-10-PCS Alphabetic Index

These FY 2027 ICD-10-PCS Alphabetic Index entries lead to this code:

Heterotopic Bioprosthetic Valve(s), Intraluminal Device, Supplement, Atrium, Right
Direct entry for this code
Supplement, Atrium, Right, Heterotopic Bioprosthetic Valve(s), Intraluminal Device
Direct entry for this code
New Technology, Supplement, Atrium, Right, Heterotopic Bioprosthetic Valve(s), Intraluminal Device
Direct entry for this code
Anatomy or device term that leads here
Anatomy or device term that leads here
Anatomy or device term that leads here
Arteriovenous Fistula, Extraluminal Support Device, Supplement
Leads to this code's table
Supplement, Arteriovenous Fistula, Extraluminal Support Device
Leads to this code's table
New Technology, Supplement, Arteriovenous Fistula, Extraluminal Support Device
Leads to this code's table

To code arteriovenous fistula of the supplement extraluminal support device, open the FY 2027 ICD-10-PCS Alphabetic Index at Arteriovenous Fistula, then the subterms Extraluminal Support Device, Supplement. The index leads to table X2U, where the approach, Device/Substance/Technology and qualifier values shown in the breakdown above complete the seven-character code X2U93YA.

Browse the full ICD-10-PCS Alphabetic Index →

Clinical Classification (CCSR)

AHRQ groups this procedure code into these clinical categories.

CAR023
Heart valve replacement and other valve procedures (endovascular)
Clinical domain: Cardiovascular Procedures

Code History

Replaces previously assigned code(s):
  • 02U638Z — Supplement Right Atrium with Zooplastic, Perc Approach

Similar Procedure Codes

Questions About X2U93YA

Is X2U93YA a billable code?

Yes. This is a complete seven-character ICD-10-PCS code, specific enough to report Supplement Right Atrium with Intraluminal Device, Heterotopic Bioprosthetic Valve(s), Percutaneous Approach, New Technology Group 10 on inpatient claims from October 1, 2026 through September 30, 2027.

What do the characters in X2U93YA mean?

The code breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character 2 is the Body System (Cardiovascular System); the 3rd character U is the Operation (Supplement); the 4th character 9 is the BodyPart (Atrium, Right); the 5th character 3 is the Approach (Percutaneous); the 6th character Y is the Device/Substance/Technology (Intraluminal Device, Heterotopic Bioprosthetic Valve(s)); the 7th character A is the Qualifier (New Technology Group 10).

What MS-DRG does X2U93YA group to?

On an inpatient stay, Supplement Right Atrium with Intraluminal Device, Heterotopic Bioprosthetic Valve(s), Percutaneous Approach, New Technology Group 10 maps to MS-DRGs 266, 267, with relative weights from 4.7211 to 5.9374. The MS-DRG sets the fixed Medicare payment for the stay.